Rare Lysosomal Disease – Is Good Medicine Worth it?
John A. Barranger, MD
Professor, University of Pittsburgh, Pittsburgh, PA
Consultant, Genzyme Corporation
2. Summarize the aspects of these disorders interesting to rheumatologists.
3. Restate therapeutic modalities that are successful in the treatment of these disorders.
Disclosure: Dr. Barranger has nothing to disclose